S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.88 (-0.24%)
AAPL   189.91 (+0.29%)
MSFT   378.73 (-0.03%)
META   327.15 (-1.52%)
GOOGL   132.45 (-1.88%)
AMZN   146.05 (-0.18%)
TSLA   239.79 (-1.78%)
NVDA   467.70 (-2.85%)
NIO   7.27 (+1.25%)
BABA   74.88 (+0.28%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.26 (-3.12%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.07%)
GE   121.80 (+2.47%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.25%)
PFE   30.47 (+1.30%)
PYPL   57.62 (-0.60%)
XOM   102.74 (+0.39%)
S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.88 (-0.24%)
AAPL   189.91 (+0.29%)
MSFT   378.73 (-0.03%)
META   327.15 (-1.52%)
GOOGL   132.45 (-1.88%)
AMZN   146.05 (-0.18%)
TSLA   239.79 (-1.78%)
NVDA   467.70 (-2.85%)
NIO   7.27 (+1.25%)
BABA   74.88 (+0.28%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.26 (-3.12%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.07%)
GE   121.80 (+2.47%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.25%)
PFE   30.47 (+1.30%)
PYPL   57.62 (-0.60%)
XOM   102.74 (+0.39%)
S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.88 (-0.24%)
AAPL   189.91 (+0.29%)
MSFT   378.73 (-0.03%)
META   327.15 (-1.52%)
GOOGL   132.45 (-1.88%)
AMZN   146.05 (-0.18%)
TSLA   239.79 (-1.78%)
NVDA   467.70 (-2.85%)
NIO   7.27 (+1.25%)
BABA   74.88 (+0.28%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.26 (-3.12%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.07%)
GE   121.80 (+2.47%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.25%)
PFE   30.47 (+1.30%)
PYPL   57.62 (-0.60%)
XOM   102.74 (+0.39%)
S&P 500   4,567.80 (+0.38%)
DOW   35,950.89 (+1.47%)
QQQ   388.88 (-0.24%)
AAPL   189.91 (+0.29%)
MSFT   378.73 (-0.03%)
META   327.15 (-1.52%)
GOOGL   132.45 (-1.88%)
AMZN   146.05 (-0.18%)
TSLA   239.79 (-1.78%)
NVDA   467.70 (-2.85%)
NIO   7.27 (+1.25%)
BABA   74.88 (+0.28%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.26 (-3.12%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.07%)
GE   121.80 (+2.47%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.25%)
PFE   30.47 (+1.30%)
PYPL   57.62 (-0.60%)
XOM   102.74 (+0.39%)

ObsEva Stock Price, News & Analysis (NASDAQ:OBSV)

$0.04
0.00 (0.00%)
(As of 11/29/2023 ET)
Compare
Today's Range
$0.02
$0.04
50-Day Range
$0.04
$0.09
52-Week Range
$0.08
$2.14
Volume
66,913 shs
Average Volume
8.94 million shs
Market Capitalization
$3.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

OBSV stock logo

About ObsEva Stock (NASDAQ:OBSV)

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.

OBSV Stock Price History

OBSV Stock News Headlines

StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV)
ObsEva (NASDAQ:OBSV) Now Covered by StockNews.com
Why Microsoft Just Placed A Huge Bet On Nuclear
Even with aggressive expansion and acquisition of solar and wind farms, renewable energy isn’t anywhere close to providing the energy that Microsoft demands.
ObsEva SA OBSN
ObsEva SA OBSEF
ObsEva (NASDAQ: OBSV)
ObsEva Files Year End 2022 Financial Statements
Why Microsoft Just Placed A Huge Bet On Nuclear
Even with aggressive expansion and acquisition of solar and wind farms, renewable energy isn’t anywhere close to providing the energy that Microsoft demands.
Why Is ObsEva (OBSV) Stock Up 93% Today?
Why ObsEva (OBSV) Stock Is Down 36% Today
ObsEva Announces Dismissal of Moratorium Proceedings
ObsEva SA (OBSV) Reports Q3 Loss, Lags Revenue Estimates
ObsEva SA (OBSV)
See More Headlines
Receive OBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ObsEva and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
11/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:OBSV
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

Net Income
$-58,380,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20.11 million
Book Value
$0.41 per share

Miscellaneous

Free Float
66,743,000
Market Cap
$3.12 million
Optionable
Not Optionable
Beta
0.68
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • William M. Brown
    Chief Executive & Financial Officer
  • Elke Bestel
    VP, Head-Drug Safety & Pharmacovigilance
  • Katja Buhrer
    Chief Strategy Officer














OBSV Stock Analysis - Frequently Asked Questions

How have OBSV shares performed in 2023?

ObsEva's stock was trading at $0.1450 on January 1st, 2023. Since then, OBSV stock has decreased by 72.4% and is now trading at $0.04.
View the best growth stocks for 2023 here
.

How were ObsEva's earnings last quarter?

ObsEva SA (NASDAQ:OBSV) posted its quarterly earnings results on Thursday, November, 4th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.23.

What other stocks do shareholders of ObsEva own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ObsEva investors own include Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB), Trevena (TRVN), Zosano Pharma (ZSAN), Vaxart (VXRT), VBI Vaccines (VBIV), Bionano Genomics (BNGO) and ADMA Biologics (ADMA).

When did ObsEva IPO?

(OBSV) raised $98 million in an initial public offering on Thursday, January 26th 2017. The company issued 6,500,000 shares at $14.00-$16.00 per share. Credit Suisse, Jefferies and Leerink Partners served as the underwriters for the IPO.

Who are ObsEva's major shareholders?

ObsEva's stock is owned by many different institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of ObsEva?

Shares of OBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:OBSV) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -